Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Experimental Cancer Drug Restores Memory in Mouse Model of Alzheimer’s

April 1, 2015 12:37 pm | by Yale University | News | Comments

Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer’s given an experimental cancer drug, Yale School of Medicine researchers reported in the journal Annals of Neurology. Read more...

TOPICS:

Actavis Selling Australian Generic Drug Unit to Amneal

April 1, 2015 10:30 am | by Associated Press | News | Comments

Actavis PLC is selling its generic drug business in Australia to privately-held Amneal Pharmaceuticals for an undisclosed amount. Read more...

TOPICS:

Paracetamol is Ineffective for Lower Back Pain

April 1, 2015 10:19 am | News | Comments

Paracetamol is not effective in the treatment of spinal pain and provides negligible benefits for osteoarthritis, according to a study published in The BMJ. Read more...

TOPICS:
Advertisement

Texas Measure Cuts HIV Funds, Boost Abstinence Education

April 1, 2015 10:15 am | by Paul J. Weber, Associated Press | News | Comments

Texas would cut $3 million from programs to prevent HIV and other sexually transmitted diseases and spend that money instead on abstinence education under a contentious Republican-sponsored measure tucked into the state budget Tuesday night. Read more...

TOPICS:

Merck's HPV Vaccine Now Available in Canada

April 1, 2015 10:12 am | News | Comments

Merck, known as MSD outside the United States and Canada, announced that Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merck's 9-valent human papillomavirus (HPV) vaccine, is now available in Canada.  

TOPICS:

U.S. RA Treatment Market to Reach $9.3B by 2020

April 1, 2015 10:03 am | News | Comments

The US treatment market for Rheumatoid Arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.5%, says business intelligence provider GBI Research. Read more...

TOPICS:

Pill Manufacturing – A Second Revolution?

April 1, 2015 9:56 am | by Paul Roossin, Science Director Nanotronics Imaging | Articles | Comments

Pills have been used to deliver a measured medicinal dose for over three millennia. When the British artist, inventor, and watchmaker William Brockedon produced a compression machine for graphite to produce a better pencil lead, his invention was noticed by a savvy pharmaceutical company who hired him to retool the instrument to produce tablets. Read more...

TOPICS:

Medieval Remedy Found to be Highly Effective Against MRSA

March 31, 2015 1:37 pm | by Stephanie Guzowski, Editor | News | Comments

British researchers recently found that a thousand-year-old Anglo-Saxon treatment for eye infections works as an antibiotic against MRSA. Read more...

TOPICS:
Advertisement

Blood-Based Biomarkers Could Enable Accurate TB Tests for Diagnosis

March 31, 2015 11:48 am | by Emory University | News | Comments

Researchers have identified blood-based biomarkers in patients with active tuberculosis (ATB) that could lead to new blood-based diagnostics and tools for monitoring treatment response and cure. Read more...

TOPICS:

Quintiles, Quest to Join to Provide Global Clinical Trials Lab Services

March 31, 2015 11:38 am | News | Comments

Quintiles and Quest Diagnostics announced a definitive agreement to form a global clinical trials laboratory services business. Read more...

TOPICS:

Publication Bias, 'Spin,' Raise Questions About Anxiety Drugs

March 31, 2015 11:32 am | by Oregon State University | News | Comments

A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders. Read more...

TOPICS:

Arizona Governor Signs Abortion Drug Notification Mandate

March 31, 2015 11:22 am | by Bob Christie and Ryan Van Velzer, Associate Press | News | Comments

Gov. Doug Ducey signed a bill Monday that requires abortion providers in Arizona to tell women they can reverse the effects of a drug-induced abortion and also bars women from buying any health care plan through the federal marketplace that includes abortion coverage. Read more...

TOPICS:

Merck Serono, Intrexon Agree to Develop, Commercialize CAR-T Therapy

March 31, 2015 10:21 am | News | Comments

Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. Read more...

TOPICS:

Britain to Offer All Infants Meningitis B Vaccine

March 31, 2015 10:17 am | by Associated Press | News | Comments

Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC. Read more..

TOPICS:

Development, Commercialization of Antibacterial Drugs to Speed Up

March 31, 2015 10:12 am | News | Comments

The growing threat posed by multi-drug resistant gram-negative organisms (MDR-GNBs) is lending a sense of urgency to the development of antibacterial drugs worldwide. Upcoming regulatory reforms to lower R&D costs and provide incentives for new drug identification will create attractive opportunities for pharmaceutical manufacturers. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading